nach oben

Reactions Weekly

Erschienen in:

01.08.2019 | Case report

Antituberculars/moxifloxacin/prednisone

Various toxicities: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 69-year-old man developed tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) during treatment with ethambutol, isoniazid, moxifloxacin, prednisone, pyrazinamide and rifampicin for disseminated Mycobacterium tuberculosis (MTB) infection. He also developed neuropathy during treatment with isoniazid, and vision impairment secondary to cataract during treatment with prednisone [routes not stated; not all dosages stated]. …

Mohammadian M, et al. Symptomatic central nervous system tuberculoma, a case report in the United States and literature review. IDCases 17: 2019. Available from: URL: http://doi.org/10.1016/j.idcr.2019.e00582 - Iran

Titel: Antituberculars/moxifloxacin/prednisone
Various toxicities: case report
Publikationsdatum: 01.08.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-65802-y

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Antituberculars/moxifloxacin/prednisone

Various toxicities: case report

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Dexamethasone/methylprednisolone/rituximab

Ceftriaxone

Heparin

Warfarin

Bevacizumab

Immunosuppressants